Clinical Trial Update: Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial evaluating tenecteplase for Acute Respiratory Distress Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Acute Respiratory Distress Syndrome | Phase 1 | Status: WITHDRAWN